The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy

Grau, Emma Garcia; Vizcaı´no, Miguel A´ ngel Checa; Oliveira, Ma´rio; Juan´ os, Judith Lleberia; Collado, Ramon Carreras; Estevez, Yolanda Canet
January 2011
Obstetrics & Gynecology International;2011, Vol. 2011, p1
Academic Journal
After an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most costeffective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropriate way to conceive future pregnancies. Methods. Between 1998 and 2008, 144 patients were submitted to medical treatment for an EP and performed HSG 3 months after the event. Results. 72.2% of normal HSG, 18.8% with unilateral obstruction, 6.3% tubal patency with defect, and 2.8% bilateral obstruction. Conclusion. Routine HSG following medical treatment for an EP does not seem necessary, as it does not change the initialmanagement in 97.2% of the cases, but might be considered in selected risk cases, permitting timely referral of patients to in vitro fertilization.


Related Articles

  • Salpingotomy or salpingectomy in tubal ectopic pregnancy: What do women prefer? van Mello, N. M.; Mol, F.; Opmeer, B. C.; de Bekker-Grob, E. W.; Essink-Bot, M. L.; Ankum, W. M.; Mol, B. W.; van der Veen, F.; Hajenius, P. J. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2010, Vol. 21 Issue 5, p687 

    There is an ongoing debate whether tubal ectopic pregnancy should be treated by salpingotomy or salpingectomy. It is unknown which treatment women prefer in view of the potentially better fertility outcome but disadvantages of salpingotomy. This study investigated women surgically treated for...

  • Predictors of Success of Methotrexate Treatment in Women with Tubal Ectopic Pregnancies. Lipscomb, Gary H.; McCord, Marian L.; Stovall, Thomas G.; Huff, Genelle; Portera, S. Greg; Ling, Frank W. // New England Journal of Medicine;12/23/99, Vol. 341 Issue 26, p1974 

    Background: The use of methotrexate for the treatment of women with tubal ectopic pregnancies is now common practice. However, the clinical and hormonal determinants of the success of this treatment are not known. Methods: We studied 350 women with tubal ectopic pregnancies who were treated with...

  • Is D&C always necessary to diagnose ectopic pregnancy?  // Contemporary OB/GYN;Dec2003, Vol. 48 Issue 12, p97 

    The article presents the responses of readers on the need for dilatation and curettage (D&C) of the uterus to diagnose ectopic pregnancy. A reader says selected patients can benefit from methotrexate without undergoing D&C. Another reader says D&C is not a treatment for tubal ectopics.

  • Spontaneous bilateral tubal pregnancy following hysterosalpingography. Seol, Hyun-Joo; Tong, Seo-Yun // Archives of Gynecology & Obstetrics;May2014, Vol. 289 Issue 5, p923 

    The article presents a case study of a 29-year-old female patient who was referred to a medical clinic after being diagnosed with a spontaneous tubal pregnancy following hysterosalpingography. Salpingostomy surgical intervention was performed to resolve the tubal pregnancy. Other topics include...

  • The Ethics of Ectopic Pregnancy: A Critical Reconsideration of Salpingostomy and Methotrexate. Kaczor, Christopher // Linacre Quarterly;Aug2009, Vol. 76 Issue 3, p265 

    Ethicists have continued to debate about two means of treating ectopic pregnancy, namely, the removal of the embryo from the tube (salpingostomy) and the use of methotrexate. This article examines the major arguments in favor of considering salpingostomy intentional killing. The article goes on...

  • Fertility Depends on Previous Medical History.  // Fertility Weekly;8/23/2004, p6 

    This article focuses on the study by researcher Arnelle Gervaise and colleagues regarding the ectopic pregnancy (EP). Increasingly more women have EP that require medical management. The authors studied a cohort of 158 women treated with methotrexate for tubal pregnancies. The Kaplan-Meier...

  • Increment in β-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate. da Costa Soares, Roberto; Junior, Júlio Elito; Camano, Luiz // Archives of Gynecology & Obstetrics;Oct2008, Vol. 278 Issue 4, p319 

    To evaluate the increment in β-hCG levels (%) in the 48-h interval prior to treatment as a predictor of therapeutic success in the management of ectopic pregnancy with methotrexate. A prospective observational study was carried out between April 2002 and November 2006 at the Federal...

  • Pronóstico reproductivo posterior a un embarazo ectópico según modalidad de tratamiento. Silva G., María Carolina; Errázuriz V., Joaquín; Urzúa V., María José; Sumar U., Francisco; Troncoso R., Fernando; Rondini F.-D., Carlos; Insunza F., Alvaro // Revista Chilena de Obstetricia y Ginecología;2014, Vol. 79 Issue 4, p262 

    Introduction: It is estimated that 20-60% of patients with ectopic pregnancy, will develop infertility on the future, but knowledge about this matter is scarce. Aims: To compare fertility rates after ectopic pregnancy, among medical treatment with methotrexate and surgery, in patients without...

  • Treatment of Unruptured Ectopic Pregnancy.  // Fertility Weekly;7/25/2005, p1 

    Focuses on the study from Brazil which stated that in the treatment of unruptured ectopic pregnancy, tubal patency rates are similar when treated with methotrexate and expectant management. Changes in the developments in diagnostics for the treatment of ectopic pregnancy from that of saving the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics